Friday, March 20, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
No Result
View All Result

Moderna Stock Jumped Because It Just Unveiled a Two-in-One Vaccine for Covid and the Flu

Daily Remedy by Daily Remedy
September 10, 2021
in
0

Moderna plans to announce the development of a vaccine candidate that will protect against Covid-19 and the flu, to be known as mRNA-1073. The company will also announce a pediatric vaccine called mRNA-1365, which combines its experimental respiratory syncytial virus vaccine with its experimental human metapneumovirus vaccine.

The news came less than an hour before the company begins an investor event intended to discuss the company’s clinical development pipeline. Top Moderna (ticker: MRNA) executives, including CEO Stéphane Bancel, newly appointed chief medical officer Dr. Paul Burton, and the company’s president, Dr. Stephen Hoge, were due to appear.

Source: Barrons

https://www.barrons.com/articles/moderna-stock-covid-flu-vaccine-51631189754

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

summary This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices. key topics Deceptive pricing strategies in healthcare The role of brand perception and pricing manipulation The concept of drip pricing and hidden costs The rise of healthcare consumerism and patient agency Strategies for patients to identify and avoid deceptive practices Chapters 00:00 The Evolution of the GLP-1 Telemedicine Market 01:12 How Pricing Is Obscured and Perceived Discounts Are Created 02:11 TrumpRx: Coupon Aggregator or Discount Store? 03:12 Why Price Deception Thrives in Healthcare 04:12 The Membership Fee Illusion and Hidden Costs 05:10 Brand Recognition and Drip Pricing Strategies 06:17 The Impact of Brand and Anchor Pricing on Perceived Value 07:16 The Role of Price Drip Strategies in Healthcare Pricing 08:15 The Rise of Healthcare Consumerism and Patient Agency 09:14 How to Protect Yourself from Deceptive Pricing Practices 10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

No Result
View All Result

© 2026 Daily Remedy